BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6331578)

  • 1. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE; Martini A; Sacerdote P; Mantegazza P
    Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the opiate antagonists diprenorphine and naloxone and of selected opiate agonists on feeding behavior in guinea pigs.
    Billington CJ; Herman BH; Bartness TJ; Levine AS; Morley JE
    Life Sci; 1990; 46(2):147-54. PubMed ID: 2153888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naloxone and Mr 2266 on thermonociceptive reactions in diabetic mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    NIDA Res Monogr; 1989; 95():528-9. PubMed ID: 2561849
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus.
    Pilcher CW; Browne JL
    NIDA Res Monogr; 1986; 75():469-72. PubMed ID: 2828994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266.
    Fanselow MS; Calcagnetti DJ; Helmstetter FJ
    Behav Neurosci; 1989 Jun; 103(3):663-72. PubMed ID: 2544207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
    Pazos A; Tristán C; Flórez J
    Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid antagonists and drinking: evidence of kappa-receptor involvement.
    Leander JD; Hynes MD
    Eur J Pharmacol; 1983 Mar; 87(4):481-4. PubMed ID: 6303802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic opioid kappa-receptor and regulation of the release of Met-enkephalin in the rat brainstem.
    Ueda H; Fukushima N; Ge M; Takagi H; Satoh M
    Neurosci Lett; 1987 Oct; 81(3):309-13. PubMed ID: 2829060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice.
    Jackson HC; Nutt DJ
    Psychopharmacology (Berl); 1991; 103(3):380-3. PubMed ID: 1647539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
    Fuller RW; Leander JD
    J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 15. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotomimesis mediated by kappa opiate receptors.
    Pfeiffer A; Brantl V; Herz A; Emrich HM
    Science; 1986 Aug; 233(4765):774-6. PubMed ID: 3016896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat.
    Jackson HC; Nutt DJ
    J Pharm Pharmacol; 1991 Sep; 43(9):640-3. PubMed ID: 1685523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naloxone and Mr 1452 on stress-induced changes in nociception of different stimuli in rats.
    Pilcher CW; Browne JL
    Life Sci; 1983; 33 Suppl 1():697-700. PubMed ID: 6686642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
    Shearman GT; Stenfors C
    Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.